Saturday, February 29 (26)

1:45 PM–2:45 PM

Studying the Acute-to-Chronic Pain Transition in Perioperative Patients (310)

Surgical injury typically results in some acute pain but, importantly, also affords a chance of transition into chronic pain and opioid use. This panel will provide a brief overview of the basic mechanisms underlying the transition from acute to chronic pain, with emphasis on pain centralization and psychosocial modulation.

One Protocol Does Not Fit All: Measuring Differences in Pain Processing to Guide Perioperative Care

Kristin Schreiber

When the Pain Really Is in Your Head: How Fibromyalgianess Influences Analgesic Response to Lumbar Spine Surgery and Interventional Pain Procedures

Andrea Nicol

Balancing Opioid Minimization and Optimal Perioperative Pain Management

Jennifer Hah

Learning Objectives:

  • Examine the tremendous variability in pain processing between individuals, which may be partially predicted using brief, well-validated preoperative assessment tools.
  • Illustrate that fibromyalgianess is not just a silly made-up word—it is a concept that time and time again has shown to lead to greater understandings of how centralized pain influences analgesic outcomes from peripherally directed interventions.
  • Determine that risk factors for chronic postoperative pain and opioids are only partially overlapping, and targeted interventions for one outcome may not passively impact the other.
Co-Presenters:

Kristin Schreiber

Jennifer Hah

Moderator:

Andrea Nicol

1:45 PM–2:45 PM

Emerging Applications for Peripheral Nerve Stimulation for Subacute and Chronic Pain Syndromes (309)

The emerging field of peripheral nerve stimulation (PNS) has captivated practitioners in novel treatment ideas for postsurgical and chronic neuropathic pain patients. This session will be a comprehensive review of evidence, techniques, and mechanisms for PNS treatments in the pain population.

Mechanisms of Peripheral Nerve Stimulation

Amitabh Gulati

Indications and Novel Techniques for the Application of PNS

Einar Ottestad

Evidence for PNS in Post-Surgical and Neuropathic Pain Syndromes

Vafi Salmasi

Learning Objectives:

  • Identify the physiology of PNS systems on neural transmissions and improvement in the perception of pain.
  • Recognize the importance of technique, including ultrasound guidance, in optimizing the efficacy of PNS for pain patients.
  • Review the evidence for PNS treatments for postsurgical and chronic neuropathic pain patients.
Co-Presenters:

Einar Ottestad

Vafi Salmasi

Moderator:

Amitabh Gulati

1:45 PM–2:45 PM

Botulinum, Biologics, and IT Therapies for Chronic Pain: Research and Reimbursement (319)

AAPM and APPD welcomes you to attend this inaugural three-session educational event where fellowship directors from across the country will discuss the fellowship selection process, provide tips for a successful match, and discuss the literature, patient selection, and billing/coding for popular Interventional procedures.

This is a non-CME event.

Botulinum and Biologics for Chronic Pain

Charles Argoff, MD

IT Pumps: Medications, Evidence, and Technique

Nalini Sehgal, MD

Botulinum and IT Therapies Evidence, Documentation, Billing and Coding

Amy Turner, RN BSN MMHC CPC CHC CHIAP

Panel Discussion

Learning objectives:

  • Explain the literature, documentation, and payment principles behind botulinum and biologic medications.
  • Explain the literature, documentation, and payment principles behind intrathecal therapies.
12:45-1:45 PM

A Fresh Look at Atypical Opioids as Frontline Analgesics: Science NOT Misconceptions

Program Overview

Opioid analgesics are an important part of our therapeutic armamentarium, but can also have serious consequences. As the pendulum swings from liberal opioid prescribing to a more measured approach, clinicians must ensure it does not swing too far. All opioids are not the same and they vary in their potential for respiratory depression, the major cause of overdose death. Three atypical opioids—buprenorphine, tapentadol, and tramadol—are currently available. Unlike conventional opioids that primarily rely on mu-opioid receptor agonism for analgesia and adverse effects, atypical opioids have additional mechanisms of action that increase the separation between desired therapeutic and unwanted effects. In particular, several groups have identified buprenorphine as a preferred opioid for chronic pain because it has a ceiling to respiratory depression. However, buprenorphine’s complex pharmacology and development history, which includes treatment of opioid use disorder, have led to longstanding misconceptions that buprenorphine is a weaker older drug with limited utility. The faculty will address misconceptions about the pharmacology, analgesic efficacy, and safety of buprenorphine, and provide recommendations on the appropriate use of buprenorphine for chronic pain, including conversion strategies for switching from conventional opioids to buprenorphine.

Faculty

Lynn R. Webster, MD
Vice President of Scientific Affairs, 
PRA Health Sciences
Salt Lake City, Utah

Richard L. Rauck, MD
President, Carolinas Pain Institute
Medical Director, Center for Clinical Research
Pain Fellowship Director,
Wake Forest University School of Medicine
Winston-Salem, North Carolina

Learning Objectives

After completing this activity, participants should be better able to:

  • Describe the pharmacologic and safety differences between conventional and atypical opioids.
  • Identify appropriate patients who would benefit from buprenorphine as a first-line opioid analgesic.
  • Describe a strategy to transition opioid therapy from full mu-opioid analgesics to buprenorphine when appropriate.

Register now! There is no registration fee to attend this CME activity.

Supported by an educational grant from BioDelivery Sciences International, Inc.

Accreditation and Credit Designation Statement

Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Center for Independent Healthcare Education (Center) and PharmaCom Group. Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Center designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
AAPA accepts AMA PRA Category 1 Credit™ for the PRA from organizations accredited by ACCME.

Nurse Practitioners
Nurse Practitioners will receive certificate of AMA PRA Category 1 Credit™ as this is an ACCME accredited program and its accreditation is recognized by Nurse Practitioner boards.

Subscribe to this RSS feed